[1]CurrentPatentAssignee:DUCHUANGSHANGHAIMEDICINETECH-CN109734655,2019,ALocationinpatent:Paragraph0030;0054-0056
Title: Inducible apoptosis as a safety switch for adoptive cell therapy.
Journal: The New England journal of medicine 20111103
Title: Eliminating cells gone astray.
Journal: The New England journal of medicine 20111103
Title: Long-term regulation of genetically modified primary hematopoietic cells in dogs.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20110701
Title: A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy.
Journal: The Journal of clinical investigation 20110401
Title: Using gene transfer to circumvent off-target effects.
Journal: Gene therapy 20080501
Title: Regulation of gene expression by synthetic dimerizers with novel specificity.
Journal: Bioorganic & medicinal chemistry letters 20031006
Title: A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.
Journal: Blood 20010301
Title: Clackson T, et al. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42.
Title: Thomis DC, et al. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Blood. 2001 Mar 1;97(5):1249-57.
